•Mark Zandi, chief economist at Moody's Analytics, warns that the US economy is flashing 'yellow flares' as weak consumer spending, falling income, and low savings persist despite 2% growth and an AI boom.
•J.P. Morgan added five Asia-Pacific currencies to its Kinexys blockchain platform, allowing institutional clients to settle payments and FX around the clock.
•Apple is lobbying the Trump administration for clearance to buy memory chips from Chinese manufacturer CXMT as the AI boom pushes up semiconductor costs
•Rising demand from AI data centres is reshaping the semiconductor market and straining global supply chains
•Uxin Limited announced the closing of a $15 million investment from parties designated by NIO Capital under previously announced share subscription agreements.
•Bristol-Myers Squibb will pay a dividend of $0.63 per share, with a trailing yield of 4.4% and payout ratios of 70% of earnings and 43% of free cash flow.
•BioCryst Pharmaceuticals said it will wind down internal drug discovery programs and close its Alabama research facility by end of 2026, pivoting to external partnerships to cut costs.
•Bank of America reiterated its 'Buy' rating and $380 price target for Apple.
•Apple is facing a cybersecurity probe after a ransomware group claimed to have published files linked to the company, though the data is reportedly from 2021.
•France's Senate passed a revised version of a bill aimed at curbing online fast-fashion retailers such as Shein, Temu owned by PDD Holdings, and AliExpress.
•LanzaTech Global, Inc. (NASDAQ: LNZA) announced its inclusion in the Russell 3000 Index effective at the open of the U.S. market on June 29, 2026, as part of the 2026 Russell Indexes reconstitution.
•Shoulder Innovations (NYSE: SI) announced the closing of two new credit facilities for an aggregate amount of up to $50 million with Stifel Venture Banking.
•Lufthansa CEO expressed strong interest in acquiring a minority stake in Portugal's flag carrier TAP, with plans for a maintenance hub in Portugal, competing with Air France-KLM.
•Korn Ferry (KFY) announced a definitive agreement to acquire AMS from OMERS Private Equity, aiming to create a global leader in talent and organizational consulting.
•Talawar Therapeutics and JATT II Acquisition Corp. announced a definitive business combination agreement to create a publicly listed biotechnology company.
•An oversubscribed $225 million concurrent PIPE will fund TALA-125 through a Phase 2b proof-of-concept study data readout in the second half of 2028.
•TALA-125 is a novel anti-IL-13 × anti-IL-18 bispecific antibody for atopic dermatitis, with clinical entry expected in Q1 2027.
•Abu Dhabi's XRG and Italy's Eni have signed agreements with Argentina's state oil company YPF to acquire minority stakes in three upstream blocks in Argentina.
•The blocks are linked to an Argentine LNG project.
